{
  "report_rows": [
    {
      "kpi": "Total revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.302B vs. cons $1.295B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total bookings",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.433B vs. cons $1.426B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Normalized EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$433M vs. cons $427M",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Total revenue",
      "prediction": "UNCHANGED",
      "answer": "guide ~$1.325B vs. cons $1.323B (Q3 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total revenue",
      "prediction": "LOWER",
      "answer": "guide ~$5.235B vs. cons $5.245B (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Free cash flow",
      "prediction": "UNCHANGED",
      "answer": "guide ~$1.800B vs. cons $1.800B (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Normalized EBITDA margin",
      "prediction": "UNCHANGED",
      "answer": "guide ~33.2% vs. cons 33.2% (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 3.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.2,
  "day5_path": "FADE",
  "day5_rationale": "Bookings reacceleration to roughly 6.5% growth and an approximately $6M normalized-EBITDA beat should initially support the shares, but an unchanged ~$5.235B FY2026 revenue midpoint versus ~$5.245B consensus would imply softer second-half revenue after the Q2 beat, limiting estimate revisions and causing part of the day-1 gain to fade.",
  "day5_confidence": "MEDIUM"
}